You compare it with a stinky pinky misleading shareholders, but think about it: in the 10Q we got a glimpse of Rotmans financials (to be validated by the 8K), and they did not have to do that. They made mistakes in the past but they re working towards being more transparent.
But what is most important to me is that they re putting their ducks in a row: no more convertible debt, CMA loan paid off, RXAir sales ongoing, Sonnett beds sales ongoing, minimal dilution in the last 6 months (48 million since March 31st, and that includes 30 million to CMA, 4 to Matthan, 2.5 for FEC.... so no toxic dilution).
Market Data 
Markets 
AI
